{"entity":{"type":"insider","cik":"0001767280","url":"/insider/0001767280","json_url":"/insider/0001767280.json","name":"Tesi Raymond Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":13,"first":"2019-05-06","last":"2024-09-16","span_basis":"filed_date"},"name_variants":[{"name":"Tesi Raymond Joseph","source":"filing","n_filings":13,"first_seen":"2019-05-06","last_seen":"2024-09-16"}],"transactions":[{"id":2360236,"accession":"0001213900-24-079121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-079121","line_url":"/filing/0001213900-24-079121#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President and CEO), Ten percent owner","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15380.0,"shares_display":"15,380","price_per_share":6.375,"price_display":"6.38","price_state":"stated","total_value":98047.5,"total_display":"98,047.50","shares_owned_after":1554106.0,"shares_owned_after_display":"1,554,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-16","scope":"insider"},{"id":9273019,"accession":"0001213900-24-035722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-035722","line_url":"/filing/0001213900-24-035722#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President and CEO), Ten percent owner","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18028.0,"shares_display":"18,028","price_per_share":8.32,"price_display":"8.32","price_state":"stated","total_value":149992.96,"total_display":"149,992.96","shares_owned_after":1538726.0,"shares_owned_after_display":"1,538,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-19","filed_date":"2024-04-24","scope":"insider"},{"id":6614418,"accession":"0001213900-22-030210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-030210","line_url":"/filing/0001213900-22-030210#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President and CEO), Ten percent owner","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6300.0,"shares_display":"6,300","price_per_share":6.41,"price_display":"6.41","price_state":"stated","total_value":40383.0,"total_display":"40,383.00","shares_owned_after":1520698.0,"shares_owned_after_display":"1,520,698","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider"},{"id":4905302,"accession":"0001213900-21-056737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-056737","line_url":"/filing/0001213900-21-056737#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President and CEO), Ten percent owner","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3626.0,"shares_display":"3,626","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":72520.0,"total_display":"72,520.00","shares_owned_after":1490674.0,"shares_owned_after_display":"1,490,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-04","scope":"insider"},{"id":5385623,"accession":"0001213900-21-055422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-055422","line_url":"/filing/0001213900-21-055422#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President and CEO), Ten percent owner","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6517.0,"shares_display":"6,517","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":130340.0,"total_display":"130,340.00","shares_owned_after":1494300.0,"shares_owned_after_display":"1,494,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-27","filed_date":"2021-10-29","scope":"insider"},{"id":5262938,"accession":"0001213900-21-054644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-054644","line_url":"/filing/0001213900-21-054644#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President and CEO), Ten percent owner","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23616.0,"shares_display":"23,616","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":472320.0,"total_display":"472,320.00","shares_owned_after":1500817.0,"shares_owned_after_display":"1,500,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-26","scope":"insider"},{"id":5538829,"accession":"0001213900-21-036352","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-036352","line_url":"/filing/0001213900-21-036352#line-2","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24351.0,"shares_display":"24,351","price_per_share":20.08,"price_display":"20.08","price_state":"stated","total_value":488968.08,"total_display":"488,968.08","shares_owned_after":1510933.0,"shares_owned_after_display":"1,510,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-09","scope":"insider"},{"id":5538826,"accession":"0001213900-21-036352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-036352","line_url":"/filing/0001213900-21-036352#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5649.0,"shares_display":"5,649","price_per_share":20.018,"price_display":"20.02","price_state":"stated","total_value":113081.682,"total_display":"113,081.68","shares_owned_after":1535284.0,"shares_owned_after_display":"1,535,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-09","scope":"insider"},{"id":7981502,"accession":"0001213900-19-016453","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-11","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.0308,"price_display":"6.03","price_state":"stated","total_value":6030.8,"total_display":"6,030.80","shares_owned_after":1540933.0,"shares_owned_after_display":"1,540,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981500,"accession":"0001213900-19-016453","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-10","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539833.0,"shares_owned_after_display":"1,539,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981497,"accession":"0001213900-19-016453","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-9","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539733.0,"shares_owned_after_display":"1,539,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981495,"accession":"0001213900-19-016453","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-8","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539633.0,"shares_owned_after_display":"1,539,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981490,"accession":"0001213900-19-016453","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-7","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539533.0,"shares_owned_after_display":"1,539,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981487,"accession":"0001213900-19-016453","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-6","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539433.0,"shares_owned_after_display":"1,539,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981484,"accession":"0001213900-19-016453","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-5","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539333.0,"shares_owned_after_display":"1,539,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981479,"accession":"0001213900-19-016453","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-4","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539233.0,"shares_owned_after_display":"1,539,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981476,"accession":"0001213900-19-016453","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-3","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539133.0,"shares_owned_after_display":"1,539,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981472,"accession":"0001213900-19-016453","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-2","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":596.0,"total_display":"596.00","shares_owned_after":1539033.0,"shares_owned_after_display":"1,539,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":7981468,"accession":"0001213900-19-016453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-016453","line_url":"/filing/0001213900-19-016453#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.9239,"price_display":"5.92","price_state":"stated","total_value":592.39,"total_display":"592.39","shares_owned_after":1539933.0,"shares_owned_after_display":"1,539,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":8570366,"accession":"0001213900-19-015380","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-19-015380","line_url":"/filing/0001213900-19-015380#line-3","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.9095,"price_display":"6.91","price_state":"stated","total_value":6909.5,"total_display":"6,909.50","shares_owned_after":1538933.0,"shares_owned_after_display":"1,538,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":8570362,"accession":"0001213900-19-015380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-015380","line_url":"/filing/0001213900-19-015380#line-2","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":7.1431,"price_display":"7.14","price_state":"stated","total_value":6428.79,"total_display":"6,428.79","shares_owned_after":1537933.0,"shares_owned_after_display":"1,537,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":8570358,"accession":"0001213900-19-015380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-015380","line_url":"/filing/0001213900-19-015380#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":720.0,"total_display":"720.00","shares_owned_after":1537033.0,"shares_owned_after_display":"1,537,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":8432409,"accession":"0001640334-19-001033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640334-19-001033","line_url":"/filing/0001640334-19-001033#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","shares_owned_after":1536933.0,"shares_owned_after_display":"1,536,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-04","scope":"insider"},{"id":8657385,"accession":"0001640334-19-000758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640334-19-000758","line_url":"/filing/0001640334-19-000758#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (Chairman), Ten percent owner","officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11100.0,"shares_display":"11,100","price_per_share":9.9,"price_display":"9.90","price_state":"stated","total_value":109890.0,"total_display":"109,890.00","shares_owned_after":1526933.0,"shares_owned_after_display":"1,526,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-02","filed_date":"2019-05-06","scope":"insider"},{"id":8292014,"accession":"0001640334-19-000793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640334-19-000793","line_url":"/filing/0001640334-19-000793#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11100.0,"shares_display":"11,100","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":99900.0,"total_display":"99,900.00","shares_owned_after":1526933.0,"shares_owned_after_display":"1,526,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-02","filed_date":"2019-05-09","scope":"insider"},{"id":8247597,"accession":"0001640334-19-000942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640334-19-000942","line_url":"/filing/0001640334-19-000942#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767280","owner_name":"Tesi Raymond Joseph","owner_url":"/insider/0001767280","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11100.0,"shares_display":"11,100","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":119325.0,"total_display":"119,325.00","shares_owned_after":1526933.0,"shares_owned_after_display":"1,526,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-02","filed_date":"2019-05-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001711754","name":"Inmune Bio, Inc.","url":"/issuer/0001711754","role":"Director, Officer (President and CEO), Ten percent owner","n_filings":13,"first_seen":"2019-05-06","last_seen":"2024-09-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001767280","retrieved_at":"2026-08-22T00:39:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}